Lithium Ion

Lithium Ion

SCHEMBL31705051

O=C([O-])c1cncc(N2CCOC3(CC3)C2)n1.[Li+]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ TARDBP Q13148 1/20 0.36
▸ CYP11B1 P15538 2/20 0.33
▸ CYP11B2 P19099 2/20 0.33
▸ FFAR2 O15552 3/20 0.32
▸ CHRM2 P08172 2/20 0.32
▸ CHRM3 P20309 2/20 0.32
▸ LRRK2 Q5S007 3/20 0.32
▸ VNN1 O95497 1/20 0.31
▸ OGA O60502 1/20 0.31
▸ KCNJ1 P48048 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL31705742 1.00 TARDBP (0.36) TARDBPCYP11B1CYP11B2FFAR2CHRM2
SCHEMBL31706406 0.88 RBP4 (0.37) TARDBPFFAR2CHRM2CHRM3LRRK2
SCHEMBL31705022 0.84 CRBN (0.39) TARDBPFFAR2CHRM2CHRM3LRRK2
Lithium Ion SCHEMBL31706366 0.81 ALDH1A1 (0.43) —
Lithium Ion SCHEMBL31705448 0.81 ALDH1A1 (0.43) —
Lithium Ion SCHEMBL31705320 0.69 CASP1 (0.33) —
Lithium Ion SCHEMBL31706297 0.69 CASP1 (0.33) —
Potassium Ion SCHEMBL31705065 0.68 CKS1B (0.39) —
SCHEMBL25339027 0.65 SMPD3 (0.44) —
SCHEMBL31560447 0.65 KDM4E (0.47) TARDBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215110-A1 NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS LES LABORATOIRES SERVIER (FR) 2025-10-16 — — WO disclosed
Send feedback